The University of Maryland Center for Vaccine Development is conducting a study of an investigational H7N9 Influenza vaccine.

The purpose of the study is to assess whether this H7N9 flu shot with or without the AS03 adjuvants is safe and does not cause unacceptable or intolerable side effects, and to see how the body reacts to different strengths of this H7N9 flu shot when it is given with or without the AS03 adjuvants. Adjuvants are substances that can stimulate the immune system.

Healthy male and female volunteers who are 19 or older are needed to participate in this study. The study will take about 13 months and involves two vaccinations approximately three weeks apart and up to seven clinic visits. Volunteers will be compensated up to $1,200 for completion of all study visits and procedures.

For details, contact the recruiting office at the Center for Vaccine Development at 410-706-6156 betwen 8 a.m. and 4 p.m..